SenesTech, Inc.

Equities

SNES

US81720R5054

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 14/05/2024 BST			5-day change	1st Jan Change
0.646 ^USD	-6.38%		-21.23%	-49.13%

05-09	SenesTech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
05-09	Transcript : SenesTech, Inc., Q1 2024 Earnings Call, May 09, 2024

SenesTech, Inc. Announces Exclusive Distribution Agreement and Initial Order for Evolve Soft Bait in Hong Kong and Macau

December 18, 2023 at 02:01 pm

SenesTech, Inc. announced entry into a Distribution Agreement with Fruit Tree Limited, a pest control service provider, manufacturer and distributor headquartered in Hong Kong. The agreement with Fruit Tree Limited includes both a substantial initial stocking order and annual minimums.

Latest news about SenesTech, Inc.

SenesTech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
Transcript : SenesTech, Inc., Q1 2024 Earnings Call, May 09, 2024	05-09
Earnings Flash (SNES) SENESTECH Reports Q1 Revenue $415,000, vs. Street Est of $429,000	05-09	MT
SenesTech, Inc. Launches Evolve Mouse	05-02	CI
Certain Warrants of SenesTech, Inc. are subject to a Lock-Up Agreement Ending on 26-FEB-2024.	02-25	CI
Certain Common Stock of SenesTech, Inc. are subject to a Lock-Up Agreement Ending on 26-FEB-2024.	02-25	CI
Transcript : SenesTech, Inc., Q4 2023 Earnings Call, Feb 21, 2024	02-21
SenesTech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	02-21	CI
SenesTech Taps Q-chem to Distribute Pest Control Product in Netherlands	02-15	MT
SenesTech, Inc. Announces Exclusive Distribution Agreement with Q-Chem for Evolve Soft Bait in Netherlands	02-15	CI
Senestech, Inc. Announces Exclusive Distribution Agreement for Evolve Soft Bait in Australia and New Zealand	02-08	CI
SenesTech Signs Distribution Deal With Agro Technic	02-05	MT
Senestech Announces Exclusive Distribution Agreement and Initial Order for Evolve? Soft Bait in Singapore	02-05	CI
Senestech Signs Poppe Enterprises for Evolve? Distribution in Grain Management Market	01-29	CI
SenesTech Partners with Global Leader in Irrigation Solutions to Expand Evolve Soft Bait to Open Field Agriculture Applications	01-08	CI
Sector Update: Health Care Stocks Gain Late Afternoon	01-02	MT
Sector Update: Health Care Stocks Rise Tuesday Afternoon	01-02	MT
Top Midday Gainers	01-02	MT
SenesTech Expands Distribution Deal With Pesterminators; Shares Rise	01-02	MT
SenesTech, Inc. Announces the Expansion of Its Distribution Agreement with Pesterminators Pvt Ltd to Include the Deployment of Evolve	01-02	CI
Top Premarket Gainers	12-28	MT
SenesTech, Inc. Announces Exclusive Distribution Agreement and Initial Order for Evolve Soft Bait in Hong Kong and Macau	12-18	CI
SenesTech's ContraPest Registered for Use in Puerto Rico to Combat Rat Infestations	12-04	CI
SenesTech Closes $5 Million Public Offering	11-29	MT
Top Midday Decliners	11-28	MT

Chart SenesTech, Inc.

Duration

Period

More charts

Company Profile

SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company has two product lines of fertility control products: ContraPest and Evolve. Its product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions of the rat population. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. Additionally, ContraPest does not cause illness in rats, and, therefore, it does not change behavior or result in bait aversion. ContraPest offers a new tool used in coordination with rodenticides as part of an integrated pest management program. The Company's technology can also be applied to other mammalian species.

Sector

Biotechnology & Medical Research

Calendar

07/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for SenesTech, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.646 USD

Average target price

3.5 USD

Spread / Average Target

+441.80%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
SENESTECH, INC.	-49.13%	3.32M
MODERNA, INC.	+29.03%	49.18B
IQVIA HOLDINGS INC.	-0.10%	42.11B
LONZA GROUP AG	+43.45%	40.37B
CELLTRION, INC.	-5.26%	28.85B
ICON PUBLIC LIMITED COMPANY	+11.48%	26.09B
ALNYLAM PHARMACEUTICALS, INC.	-22.74%	18.71B
BIO-TECHNE CORPORATION	+9.06%	13.26B
MEDPACE HOLDINGS, INC.	+30.01%	12.32B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.51%	11.99B

Other Biotechnology & Medical Research